At Scott & White, You’re Treated as a Person, Not a Diagnosis
- Our Tumor Board Sets Us Apart
As a myeloma patient at Scott & White, in addition to having a highly experienced Integrated Care Team, you’ll also benefit from the expertise of the Scott & White Tumor Board.
Led by senior staff, our multidisciplinary board consists of blood malignancy experts who discuss available approaches to care and formulate patient-specific treatment plans. This treatment planning helps ensure you receive the highest quality, individualized care.
Scott & White Spearheads Progressive New Myeloma Treatments
The key to curing myeloma lies in developing new treatments. And we’re working on that here. Scott & White Cancer Institute leads the way in developing innovative new treatments for myeloma and other blood disorders.
Talk to your physician about whether you’re a candidate for participating in one of our clinical trials.
One of our faculty members is involved in research, developing some of these new and innovative agents. And some of those agents are available only here at our institution for clinical trial. So I think when we get through patients who've been treated with standard medicines, and have had relapses, there are some additional options here that might not be available at the routine private practice hematology clinic.
Emotionally for the patient — and the doctors, too — it’s a better time now to get multiple myeloma. The treatment options and the prognosis are much more optimistic.
With the expertise and skill of our top-notch team of hematologist/oncologists — coupled with advancements in targeted therapies — the outlook for remission from myeloma is better than ever.
Our specialists here at Scott & White Healthcare are on the leading edge of developing innovative treatments. Our physicians, research scientists and many others understand the importance of providing new hope for the clinical care of your disease, helping make remission quicker and safer for you.
Moreover, your team of premier hematologist/oncologists have a wealth of experience in treating myeloma. And experience matters. We treat a high volume of blood malignancies here. You can have confidence in us. Our Myeloma Team is committed to providing you with comprehensive, personalized care focused on bringing you to remission.
The group we have pulled together enjoys doing hematologic things. It’s one of the larger groups in the state. We offer a breadth of experiences and services that is difficult to duplicate.
As a Scott & White patient, you’ll also benefit from having a multidisciplinary team — your Integrated Care Team — working together to provide you with the best care possible at all stages of your myeloma treatment.
The members of your Integrated Care Team bring together the collective skill and expertise from all the specialties and subspecialties involved in your care, which can include:
- Bone marrow transplant group
- Radiation oncology
- Pediatric hematology
- Oncology social work
- And any other specialties necessary to your care
Integrated Care Team members receive training in the most up-to-date medical, radiation and surgical therapies. And because Scott & White is a research institute and a teaching hospital, our oncologists can offer you the most advanced treatments available. We lead the way in developing new therapies.
Our patients benefit by having a large group of doctors and a team review their cases together to come up with a consensus plan. Even though, of course, it's tailored to them specifically.
Collaborative Care and Expertise Help Ensure the Best Outcome for You
Sophisticated cancer care takes teamwork. That’s why Scott & White promotes a collaborative environment.
Your Integrated Care Team will met to discuss your specific needs and determine the best treatment options for you to consider. Then your lead physician will talk with you and, if you’d like, your family, about the team’s recommendations.
Together, you and your lead physician will decide which treatment choice is best for you.
Throughout your treatment, your physicians will continue to meet regularly to discuss your care. This ongoing, close collaboration helps ensure the best outcome for you.
Following active treatment, your Integrated Care Team will work with you to create the most appropriate follow-up care plan.
Factors That Impact Your Treatment
Your treatment options for myeloma generally depend on these factors:
- Whether you have symptoms
- How fast your myeloma is advancing
- Your age and general health
- Your personal preference
When I see patients, they do tend to have a lot of questions — a lot of unanswered questions at that point — and so the first appointment tends to be a fairly extensive appointment, at which time we talk about the disease, the disease process, what to expect, and what we can do to help them.
Your Treatment Options
At Scott & White, we explore every treatment option. In some cases, your myeloma treatment will include a combination of approaches. Treatment options include:
- Active Surveillance
- Autologous Blood Stem-Cell Transplant
- Radiation Therapy
- Clinical Trials
At Scott & White, treatment goals for myeloma generally are centered on inducing remission.